Skip to content

Independent register of U.S. FDA drug recalls · updated Oct 10, 2026

FDA Drug Recalls

437 recalls, newest first

Mar 28, 2013 Class II · Moderate risk

Levoxyl (levothyroxine sodium)

Chemical contamination: emission of strong odor after package was opened.

Completed Chemical / undeclared Pfizer Inc. NDC 60793-859-01 D-260-2013

Mar 28, 2013 Class II · Moderate risk

Levoxyl (levothyroxine sodium)

Chemical contamination: emission of strong odor after package was opened.

Completed Chemical / undeclared Pfizer Inc. NDC 60793-858-01 D-259-2013

Mar 28, 2013 Class II · Moderate risk

Levoxyl (levothyroxine sodium)

Chemical contamination: emission of strong odor after package was opened.

Completed Chemical / undeclared Pfizer Inc. NDC 60793-857-01 D-258-2013

Mar 28, 2013 Class II · Moderate risk

Levoxyl (levothyroxine sodium)

Chemical contamination: emission of strong odor after package was opened

Completed Chemical / undeclared Pfizer Inc. NDC 60793-856-01 D-257-2013

Mar 28, 2013 Class II · Moderate risk

Levoxyl (levothyroxine sodium)

Chemical contamination: emission of strong odor after package was opened.

Completed Chemical / undeclared Pfizer Inc. NDC 60793-855-01 D-256-2013

Mar 28, 2013 Class II · Moderate risk

Levoxyl (levothyroxine sodium)

Chemical contamination: emission of strong odor after package was opened..

Completed Chemical / undeclared Pfizer Inc. NDC 60793-854-01 D-255-2013

Mar 28, 2013 Class II · Moderate risk

Levoxyl (levothyroxine sodium)

Chemical contamination: emission of strong odor after package was opened..

Completed Chemical / undeclared Pfizer Inc. NDC 60793-853-01 D-254-2013

Mar 28, 2013 Class II · Moderate risk

Levoxyl (levothyroxine sodium)

Chemical contamination: emission of strong odor after package was opened.

Completed Chemical / undeclared Pfizer Inc. NDC 60793-852-01 D-253-2013

Mar 28, 2013 Class II · Moderate risk

Levoxyl (levothyroxine sodium)

Chemical contamination: emission of strong odor after package was opened.

Completed Chemical / undeclared Pfizer Inc. NDC 60793-851-01 D-252-2013

Mar 28, 2013 Class II · Moderate risk

Levoxyl (levothyroxine sodium)

Chemical contamination: emission of strong odor after package was opened..

Completed Chemical / undeclared Pfizer Inc. NDC 60793-850-01 D-251-2013

Nov 8, 2012 Class I · High risk

Carboplatin Injection

Crystallization: Product is being recalled due to visible particulates identified during a retain sample inspection. Findings have identified the particles as Carboplatin crystals.

Completed Failed specification Hospira Inc. NDC 61703-339-50 D-154-2013

Nov 8, 2012 Class I · High risk

Carboplatin Injection

Crystallization: Product is being recalled due to visible particulates identified during a retain sample inspection. Findings have identified the particles as Carboplatin crystals.

Completed Failed specification Hospira Inc. NDC 61703-339-56 D-153-2013

Recalls by year

2026563
2025778
2024557
20231,122
20221,390
20211,152
2020930
20191,788
20181,681
20171,141
20161,199
20151,733
20141,309
20132,085
2012534
201134
20104
20072
20061